Surging healthcare and technology stocks helped lift the Australian sharemarket on Thursday, bucking the broader Asian market ...

If I had $100,000 to invest today, I’d back proven blue chips built to endure and compound through market cycles. The post 3 ...

Here's what to expect from the Australian-based global biotechnology company this year. The post Prediction: CSL shares could soar past $270 in 2026 appeared first on The Motley Fool Australia.

At one point in the first half Tuesday night in Park Ridge, Mike Ellis turned to his fellow coaches on the Evanston bench and ...

The Côte St. Luc Public Libary is offering bilingual Cognitive Care Kits to those experiencing cognitive decline and their ...

Hersey’s girls basketball team scored 20 points in the third quarter to pull away from Palatine with a 60-33 win Tuesday ...

Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

CSL's Gabe McDonald joined Queen City News Now from Tamps to talk about some of the missed opportunities for the Panthers.

Last year’s biggest ASX 200 flops were IDP Education (ASX:IEL) and Treasury Wine Estates (ASX:TWE) , down 53.76% and 53.55% on the year. In each case, there were good reasons for the markdowns.

CSL shares are currently trading near a 7-year low. CSL shares have been under pressure, trading near $180, due to softer profits, rising costs, and slow plasma business recovery. Despite recent ...

A report from the Australian National Audit Office into the ­Seqirus deal – and a separate agreement with US pharmaceutical company Moderna for an mRNA vaccine factory – argues the government strayed ...

CSL Ltd (ASX: CSL) has seen significant growth with its share price rising by 130% over the last ten years. Its dividend yield has increased following recent share price declines. UBS predicts steady ...